GTS Securities’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.74M | Buy |
67,767
+62,731
| +1,246% | +$4.38M | 0.21% | 76 |
|
|
2025
Q1 | $370K | Buy |
5,036
+1,060
| +27% | +$77.9K | 0.02% | 850 |
|
|
2024
Q4 | $261K | Sell |
3,976
-1,900
| -32% | -$124K | 0.01% | 973 |
|
|
2024
Q3 | $458K | Sell |
5,876
-4,140
| -41% | -$323K | ﹤0.01% | 1088 |
|
|
2024
Q2 | $781K | Sell |
10,016
-59,685
| -86% | -$4.65M | ﹤0.01% | 747 |
|
|
2024
Q1 | $4.72M | Buy |
+69,701
| New | +$4.72M | 0.01% | 168 |
|
|
2023
Q4 | – | Sell |
-33,735
| Closed | -$2.28M | – | 1566 |
|
|
2023
Q3 | $2.28M | Buy |
+33,735
| New | +$2.28M | ﹤0.01% | 290 |
|